ISSI-2 is in general considered to be a more accurate marker of β-cell function in women with GDM as it reflects an insulin resistance-adjusted insulin secretion (analogous to the disposition index obtained from the frequently sampled intravenous glucose tolerance test). The gene discussed is INS; the disease is Insulin resistance.